(S)-(+)-Dimethindene maleate: Selective M2 Antagonist for Receptor Profiling

Executive Summary: (S)-(+)-Dimethindene maleate (SKU B6734) is a highly selective muscarinic M2 receptor antagonist, with documented low affinity for M1, M3, and M4 subtypes, and also functions as a histamine H1 receptor antagonist. Its high purity (98.00%) and robust solubility in water (≥20.45 mg/mL) make it ideal for precise receptor signaling studies and standardized workflows (APExBIO). The compound's selectivity profile supports reproducible studies in autonomic regulation, cardiovascular physiology, and scalable EV research (Gong et al., 2025). APExBIO supplies (S)-(+)-Dimethindene maleate for research use, facilitating high-fidelity experiments in receptor pharmacology. Not for clinical or diagnostic use.

Biological Rationale

(S)-(+)-Dimethindene maleate is a small molecule antagonist that binds selectively to the muscarinic acetylcholine receptor subtype M2, with markedly reduced interaction with M1, M3, and M4 subtypes (APExBIO product page). Its dual activity as a histamine H1 receptor antagonist expands its utility for dissecting complex signaling pathways in both autonomic and immune responses. This selectivity is critical for distinguishing M2-mediated effects from those of other muscarinic subtypes in cardiovascular, respiratory, and neural tissues. In regenerative medicine, receptor-specific antagonists such as (S)-(+)-Dimethindene maleate enable precise modulation of cell signaling, supporting reproducibility in extracellular vesicle (EV) studies and stem cell workflows (Gong et al., 2025).

Mechanism of Action of (S)-(+)-Dimethindene maleate

(S)-(+)-Dimethindene maleate competitively inhibits the muscarinic acetylcholine receptor M2 subtype by binding to its orthosteric site, thereby preventing acetylcholine-induced receptor activation (APExBIO). The compound shows >10-fold selectivity for the M2 subtype over M1, M3, and M4 receptors under standardized in vitro conditions (buffered saline, 25°C, pH 7.4). Additionally, it blocks the histamine H1 receptor, inhibiting histamine-mediated signaling. This dual antagonism is valuable for isolating the contribution of M2 and H1 receptors in physiological and pharmacological assays. The molecular weight is 408.5 Da, and the chemical formula is C20H24N2·C4H4O4. Solubility in water is confirmed at ≥20.45 mg/mL, supporting diverse experimental designs.

Evidence & Benchmarks

• Demonstrated >10-fold selectivity for muscarinic M2 over M1, M3, and M4 receptors in radioligand binding assays under physiological buffer conditions (APExBIO, link).
• Inhibits histamine H1 receptor signaling, as validated in competitive binding and functional antagonist assays (internal review).
• Stable as a solid at room temperature when desiccated; recommended for immediate use after solution preparation to maintain efficacy (APExBIO, link).
• Used as a benchmark antagonist in studies on autonomic regulation, cardiovascular physiology, and scalable EV research (Gong et al., 2025, DOI).
• Supports reproducible pharmacological profiling in cell-based assays, minimizing off-target effects compared to non-selective antagonists (internal guide).

Applications, Limits & Misconceptions

(S)-(+)-Dimethindene maleate is primarily used in basic and translational research to dissect muscarinic M2 and histamine H1 receptor signaling. Its selectivity enables precise modulation of autonomic pathways in cardiovascular and respiratory models. The reagent is also integrated into scalable extracellular vesicle (EV) production workflows, supporting standardization and reproducibility in regenerative medicine (Gong et al., 2025). It is not intended for diagnostic or clinical therapeutic use.

For a detailed workflow integration and troubleshooting guide, see this article, which this dossier extends by providing updated evidence from scalable EV research and clarifying product-specific storage and use parameters.

Common Pitfalls or Misconceptions

• Not suitable for long-term solution storage: Solutions degrade over time; fresh preparation is required for each experiment (APExBIO).
• Not a pan-muscarinic antagonist: Selectivity for M2 means effects on M1, M3, and M4 are minimal; inappropriate for studies needing broad muscarinic inhibition.
• Research use only: Not approved for diagnostic or human/animal therapeutic applications.
• Potential for batch-to-batch variation in impure sources: Use only high-purity (98.00%) material from validated suppliers such as APExBIO.
• Cannot replace genetic knockout for receptor function studies: Pharmacological antagonism is reversible and may not fully recapitulate genetic loss-of-function models.

Workflow Integration & Parameters

(S)-(+)-Dimethindene maleate is supplied as a solid and should be stored at room temperature in a desiccated environment to preserve stability. For experimental use, dissolve in sterile water to a final concentration of at least 20.45 mg/mL. Prepare solutions immediately before use to maintain compound integrity; discard unused solution after each session. In cell-based assays, use concentrations validated in the literature or pilot studies (e.g., 1–10 μM for receptor blockade in standard buffer, pH 7.4, 37°C). The compound integrates seamlessly into EV production and receptor profiling workflows, supporting high-throughput, reproducible data acquisition. For advanced protocols in scalable EV research, see this guide, which this dossier updates with expanded data on cardiovascular and respiratory applications.

Conclusion & Outlook

(S)-(+)-Dimethindene maleate offers a rigorously characterized, selective tool for muscarinic M2 and histamine H1 receptor antagonism in pharmacological studies. Its high purity and robust solubility support reproducible workflows in autonomic regulation, cardiovascular, and regenerative medicine research. APExBIO ensures quality and traceability for research applications. For a scenario-driven perspective, see this resource, which this article updates with current benchmarks and workflow guidance. Ongoing advances in EV biomanufacturing and receptor signaling will continue to expand the utility of selective antagonists like (S)-(+)-Dimethindene maleate.